Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario 12 de Octubre (21)

2025

  1. Bronchopulmonary colonization patterns in Spanish people with cystic fibrosis: Results of a national multicentre study

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 43, Núm. 6, pp. 309-316

2024

  1. From ivacaftor to gene therapy, what has changed in cystic fibrosis?

    Revista de Patologia Respiratoria, Vol. 27, Núm. 4, pp. 138-148

  2. The cardiomyopathy of cystic fibrosis: a modern form of Keshan disease

    Frontiers in Cardiovascular Medicine, Vol. 11

2023

  1. Incidence of tumour pathology in patients with cystic fibrosis in the Community of Madrid

    Revista de Patologia Respiratoria

2022

  1. The Relation of CFTR-Genotype and Associated Comorbidities to Development of Pulmonary Atelectasis in Cystic Fibrosis Patients

    Archivos de Bronconeumologia, Vol. 58, Núm. 9, pp. 666-668

2020

  1. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

  2. What Spanish consensus meant for the treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis in the initial lung infection?

    Medicina Clinica, Vol. 154, Núm. 6, pp. 232-235

2018

  1. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

  2. Compassionate Use of Lumacaftor/Ivacaftor in Cystic Fibrosis: Spanish Experience

    Archivos de Bronconeumologia, Vol. 54, Núm. 12, pp. 614-618

2017

  1. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study

    International Journal of Antimicrobial Agents, Vol. 50, Núm. 3, pp. 334-341

  2. How are the ancient cystic fibrosis patients? Cystic fibrosis diagnosed over 60 years-old

    Respiratory Medicine Case Reports, Vol. 21, pp. 49-51

  3. Individual patterns of complexity in cystic fibrosis lung microbiota, including predator bacteria, over a 1-year period

    mBio, Vol. 8, Núm. 5

2016

  1. Bronchopulmonary infection-colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study

    Journal of Cystic Fibrosis, Vol. 15, Núm. 3, pp. 357-365

  2. Emergence of cfr-mediated linezolid resistance in a methicillin-resistant Staphylococcus aureus epidemic clone isolated from patients with cystic fibrosis

    Antimicrobial Agents and Chemotherapy, Vol. 60, Núm. 3, pp. 1878-1882

2015

  1. Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients

    Archivos de Bronconeumologia, Vol. 51, Núm. 3, pp. 140-150

2008

  1. Aislamiento de Nocardia en pacientes con fibrosis quística

    Archivos de Bronconeumologia, Vol. 44, Núm. 2, pp. 109-112

  2. Nontuberculous mycobacterial infection in patients with cystic fibrosis: A multicenter prevalence study

    Archivos de Bronconeumologia, Vol. 44, Núm. 12, pp. 679-684

2004

  1. Pacientes con fibrosis quística atendidos en las unidades de fibrosis quística de la Comunidad de Madrid: Estudio transversal de 387 casos

    Medicina Clinica, Vol. 122, Núm. 18, pp. 698-700

  2. Tratamiento antibiótico intravenoso domiciliario en las unidades de fibrosis quística de la Comunidad de Madrid

    Medicina Clinica, Vol. 122, Núm. 17, pp. 648-652

2002

  1. Life-threatening hemoptysis in cystic fibrosis: Clinical characteristics and management in 36 episodes

    Medicina Clinica, Vol. 118, Núm. 8, pp. 299-301